Loading…
Wednesday June 17, 2026 10:15am - 11:30am EDT
Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-26-656-L04-P; CME 1.25; RN 1.25

Indonesia is advancing coordinated reforms across governance, regulation, and site readiness to achieve a four-months clinical trial start-up. This session highlights regulatory alignment, WHO recognition, ethics harmonization, and CRU transformation positioning Indonesia as a credible global research partner.

Learning Objectives

Describe Indonesia’s coordinated regulatory and governance reforms to accelerate clinical trial start-up; Explain the impact of WHO-Listed Authority recognition and ethics harmonization on global collaboration; Identify operational improvements at CRU level supporting trial readiness and execution.

Chair

Endang Wahjuningtyas Hoyaranda

Speaker

Panelist
Budi Gunadi Sadikin

Panelist
Taruna Ikrar, MD

INA-CRC: Harmonizing Indonesia's Clinical Research and Our Recent Achievements
Indri Rooslamiati Supriadi

Panelist
Nina Dwi Putri


Speakers
avatar for Endang Hoyaranda

Endang Hoyaranda

President, Indonesian Association For the Study of Medicinals (IASMED), Indonesia
Endang is currently the President of the Indonesian Association for the Study of Medicinals, aside from holding her responsibilities as President of Prodia Utama which is the holding company of Prodia Group, a Group of 8 healthcare companies including the largest health laboratory... Read More →
avatar for Taruna Ikrar

Taruna Ikrar

Chairperson, Indonesia Food and Drug Authority, Indonesia
Prof. dr. Taruna Ikrar, M.D., M.Biomed, Ph.D. Since August 2024, Prof. Ikrar brings exceptional expertise in pharmacology, cardiovascular science, and neuroscience to DIA's Annual Meeting. His remarkable journey spans education at Hasanuddin University, University of Indonesia, and... Read More →
avatar for Nina Dwi Putri

Nina Dwi Putri

Head of Sub-Unit Clinical Research Implementation, Clinical Research Unit Cipto Mangunkusumo Hospital, Indonesia
avatar for Budi Gunadi Sadikin

Budi Gunadi Sadikin

Minister, Ministry of Health, Indonesia
Mr. Sadikin was the Vice Minister I of State-owned Enterprises and tasked to establish market leading and globally competitive state-owned enterprises. From July 2020 until December, 22nd 2020, he lead the National Economic Recovery and Transformation Task Force amidst the COVID-19... Read More →
avatar for Indri Supriadi

Indri Supriadi

Head of BB Binomika (Parent Organization of INA-CRC), Indonesia Ministry of Health (MOH), Indonesia
Indri Rooslamiati Supriadi is Director of Indonesia’s National Center for Biomedical and Health Genomics and the Indonesia Clinical Research Center (INA-CRC) under the Ministry of Health. She leads national efforts in precision medicine and clinical research, streamlining regulations... Read More →
Wednesday June 17, 2026 10:15am - 11:30am EDT
112AB The Pennsylvania Convention Center 1101 Arch Street Philadelphia, PA 19107 USA
  08: RegPolicy-Strategy-GlobalCollaboration, Session
  • Audience Intermediate
  • Level Intermediate
  • format csv
  • Credit Type ACPE, CME, RN
  • Interest Area Regulatory
  • Tags Session

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link